Correspondence 0001493152-23-004294 from MANGOCEUTICALS, INC. (MGRX)
MANGOCEUTICALS, INC.
Date: Feb. 10, 2023 · CIK: 0001938046 · Accession: 0001493152-23-004294
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-269240
Letter
Re:
February 10, 2023
VIA EDGAR
Division of Corporation Finance
U.S. Securities & Exchange Commission
F Street, NE
Washington, DC 20549
Attn: Office of Industrial Applications and Services
Mangoceuticals, Inc.
Registration Statement on Form S-1
File No. 333-269240
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the “Act”), the undersigned, for themselves and the other underwriters, hereby join in the request of Mangoceuticals, Inc. that the effective date of the above-referenced registration statement be accelerated so as to permit it to become effective at 4:00 p.m. Eastern time on Tuesday, February 14, 2023, or as soon thereafter as practicable.
Pursuant to Rule 460 under the Act, we wish to advise you that the underwriters have distributed as many copies of the Preliminary Prospectus dated February 3, 2023 to underwriters, dealers, institutions and others as appears to be reasonable to secure adequate distribution of the Preliminary Prospectus.
The undersigned advises that it has complied and will continue to comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
[Signature page follows]
Very
truly yours,
Boustead Securities, LLC
Show Raw Text
CORRESP
1
filename1.htm
February
10, 2023
VIA
EDGAR
Division
of Corporation Finance
U.S.
Securities & Exchange Commission
100
F Street, NE
Washington,
DC 20549
Attn:
Office of Industrial Applications and Services
Re:
Mangoceuticals,
Inc.
Registration
Statement on Form S-1
File
No. 333-269240
Ladies
and Gentlemen:
Pursuant
to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the “Act”), the undersigned,
for themselves and the other underwriters, hereby join in the request of Mangoceuticals, Inc. that the effective date of the above-referenced
registration statement be accelerated so as to permit it to become effective at 4:00 p.m. Eastern time on Tuesday, February 14, 2023,
or as soon thereafter as practicable.
Pursuant
to Rule 460 under the Act, we wish to advise you that the underwriters have distributed as many copies of the Preliminary Prospectus
dated February 3, 2023 to underwriters, dealers, institutions and others as appears to be reasonable to secure adequate distribution
of the Preliminary Prospectus.
The
undersigned advises that it has complied and will continue to comply with the requirements of Rule 15c2-8 under the Securities Exchange
Act of 1934, as amended.
[Signature
page follows]
Very
truly yours,
Boustead Securities, LLC
By:
/s/ Keith
Moore
Name:
Keith Moore
Title:
CEO
As representative of the underwriters